本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Entrada Therapeutics, Inc.

6.80
+0.38005.92%
盤後6.48-0.3200-4.71%19:30 EDT
成交量:29.18萬
成交額:193.09萬
市值:2.64億
市盈率:-1.71
高:6.81
開:6.49
低:6.29
收:6.42
52周最高:16.45
52周最低:5.02
股本:3,882.06萬
流通股本:2,271.93萬
量比:0.70
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-3.9676
每股收益(LYR):-3.4746
淨資產收益率:-54.09%
總資產收益率:-29.20%
市淨率:1.13
市盈率(LYR):-1.96

資料載入中...

2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities